Triple negative advanced breast cancer treatment with PARP inhibitors
30 Mar 2012
Triple negative advanced breast cancer treatment with PARP inhibitors
ECCO and cancer care in Europe
Managing the toxicity of aromatase inhibitors
New technology for identifying and removing micro metastases in breast cancer patients
Managing HER2 overexpression in breast cancer
Debate on the success of breast cancer screening programmes
Analysis of thirty years of clinical trial data
Cost of MRI screening for women with a family history of breast cancer
Effectiveness of breast cancer screening
Results from national breast cancer screening programme
Results from the GeparQuinto trial
The latest for advanced breast cancer